HCA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

03
Precio $426.69
Capitalización Bursátil (MRQ) $93.00B
P/E (TTM) 14.3
BPA (TTM) $29.82
Ingresos (TTM) $78.01B
Rendimiento div. 0.71%
ROE (TTM) -124.0%
Deuda/Capital (MRQ) -6.5
Rango 52S $354–$557

HCA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

04
rango
barras

La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.

Acerca de HCA Healthcare, Inc. Common Stock Descripción general de la empresa de Wikipedia

05 · wikidata

HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

History

Early years

The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was chief executive.

The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.

Growth and merger

The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.

In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.

In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,

to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.

Columbia Hospital Corporation

In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.

In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.

Recent history

On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.

In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.

In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.

In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.

In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.

In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.

In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.

In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.

Facilities

United States

As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.

Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.

In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.

In 2019 they purchased Mission Health System which operates hospitals in North Carolina.

In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.

In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.

United Kingdom

HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:

It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.

The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.

The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.

Significant areas of operation

Medical education

In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.

Controversies

Medicare billing practices lawsuit

In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.

The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.

2005 insider trading suit

In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.

COVID-19 PPE

During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.

Mission Hospital Acquisition Complaints

On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.

On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.

Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗

Wikidata ↗

sectorHealth Care industriaHealth Care empleados230 000 paísUS

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

06
Ingresos$75.60B
2016-12-31 → 2025-12-31
BPA$28.33
2016-12-31 → 2025-12-31
Flujo de caja libre$7.69B
2016-12-31 → 2025-12-31
Margen neto8.8%
2018-12-31 → 2025-12-31
Valoración y ratios 07–12

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica Tendencia a 5 años HCA promedio 5A Mediana de Pares Veredicto
P/E (TTM) 14.3promedio 5A ≈13.8 ≈13.8 16.5 Infravalorado
P/S (TTM) 1.2promedio 5A ≈1.2 ≈1.2 1.2 Valor razonable
P/C (MRQ) -14.0promedio 5A ≈-39.2 ≈-39.2 · ·
EV / EBITDA 38.7promedio 5A ≈37.3 ≈37.3 18.9 Sobrevalorado
Precio / FCF (TTM) 15.5promedio 5A ≈14.6 ≈14.6 · ·
Precio / Flujo de Caja (TTM) 8.4promedio 5A ≈7.9 ≈7.9 9.1 Infravalorado
EV / Revenue (EV / Ingresos) 1.8promedio 5A ≈1.8 ≈1.8 · ·
EV / FCF 17.7promedio 5A ≈21.8 ≈21.8 · ·
PEG Ratio (Ratio PEG) ≈0.7 · · ·

La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.

valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana

Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años

13
Rendimiento por Dividendo0.71%
Ratio de Pago10.0%
Pago anualizado≈$3.12Pago trimestral
CAGR de Dividendos a 5 años≈21.9%Por acción, ajustado por splits
Racha de Crecimiento≈5Años consecutivos de crecimiento de dividendos
Fecha ex-dividendoMontoMonedaRendimiento
Sep 16, 2026$0,78USD≈0.71%
Jun 16, 2026$0,78USD≈0.76%
Mar 17, 2026$0,78USD≈0.58%
Dic 15, 2025$0,72USD≈0.60%
Sep 16, 2025$0,72USD≈0.71%
Jun 16, 2025$0,72USD≈0.75%
Mar 17, 2025$0,72USD≈0.82%
Dic 13, 2024$0,66USD≈0.84%
Sep 16, 2024$0,66USD≈0.64%
Jun 14, 2024$0,66USD≈0.75%
Mar 14, 2024$0,66USD≈0.76%
Dic 13, 2023$0,60USD≈0.89%
Sep 14, 2023$0,60USD≈0.90%
Jun 15, 2023$0,60USD≈0.81%
Mar 16, 2023$0,60USD≈0.90%
Dic 13, 2022$0,56USD≈0.92%
Sep 15, 2022$0,56USD≈1.0%
Jun 15, 2022$0,56USD≈1.1%
Mar 16, 2022$0,56USD≈0.75%
Dic 13, 2021$0,48USD≈0.90%

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

14
Sorpresa Media 7.9%
Próximo informe Oct 22, 2026
PeríodoInformeEPS ActualEPS est.Sorpresa
30 de junio de 2026 Jul 23, 2026 $7.62 $7.54 1.0%
31 de marzo de 2026 $7.15 $7.21 -0.85%
31 de diciembre de 2025 $8.14 $7.53 8.0%
30 de septiembre de 2025 $6.96 $5.77 20.6%
30 de junio de 2025 $6.83 $6.31 8.2%
31 de marzo de 2025 $6.45 $5.84 10.5%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

15
Estado de resultados 12
Métrica Tendencia 2025202420232022202120202019201820172016
Revenue $75.60B$70.60B$64.97B$60.23B$58.75B$51.53B$51.34B$46.68B$43.61B$41.49B
SG&A Expense $548M$421M$353M$307M$337M$416M$370M$344M$340M$343M
Operating Expenses $65.77B$62.08B$57.26B$51.65B$48.92B$46.10B$46.09B$41.34B$39.23B$36.68B
Interest Expense $2.25B$2.06B$1.94B$1.74B$1.57B$1.58B$1.82B$1.75B$1.69B$1.71B
Pretax Income $9.83B$8.52B$7.71B$8.58B$9.83B$5.43B$5.24B$5.33B$4.38B$4.81B
Income Tax $2.05B$1.87B$1.61B$1.75B$2.11B$1.04B$1.10B$946M$1.64B$1.38B
Net Income $6.78B$5.76B$5.24B$5.64B$6.96B$3.75B$3.50B$3.79B$2.22B$2.89B
EPS (Basic) $28.70$22.27$19.25$19.43$21.52$11.10$10.27$10.90$6.12$7.53
EPS (Diluted) $28.33$22.00$18.97$19.15$21.16$10.93$10.07$10.66$5.95$7.30
Shares (Basic) 236,413,000258,603,000272,404,000290,348,000323,315,000338,274,000341,210,000347,297,000362,305,000383,591,000
Shares (Diluted) 239,495,000261,806,000276,412,000294,666,000328,752,000343,605,000348,226,000355,303,000372,221,000395,851,000
EBITDA $3.52B$3.31B$3.08B$2.97B$2.85B$2.72B$2.60B$2.28B$2.13B$1.97B
Balance general 22
Métrica Tendencia 2025202420232022202120202019201820172016
Cash & Equivalents $1.04B$1.93B$935M$908M$1.45B$1.79B$621M$502M$732M$646M
Short-term Investments ·····$116M$147M$47M$54M$49M
Receivables $10.87B$10.75B$9.96B$8.89B$8.10B$7.05B$7.38B$6.79B$6.50B$5.83B
Inventory $1.65B$1.74B$2.02B$2.07B$1.99B$2.02B$1.85B$1.73B$1.57B$1.50B
Other Current Assets $2.22B$1.99B$2.01B$1.78B$2.01B$1.46B$1.35B$1.19B$1.17B$1.11B
Current Assets $15.78B$16.41B$14.93B$13.64B$13.54B$12.33B$11.20B$10.21B$9.98B$9.09B
PP&E (Net) $31.14B$29.41B$27.71B$25.57B$24.06B$23.20B$22.71B$19.76B$17.89B$16.35B
PP&E (Gross) $66.28B$62.51B$58.55B$54.76B$51.35B$49.32B$47.23B$42.97B$40.08B$37.05B
Accum. Depreciation $35.13B$33.10B$30.83B$29.18B$27.29B$26.12B$24.52B$23.21B$22.19B$20.70B
Other Non-current Assets $255M$230M$184M$298M$598M$546M$480M$690M$710M$1.07B
Total Assets $60.72B$59.51B$56.21B$52.44B$50.74B$47.49B$45.06B$39.21B$36.59B$33.76B
Accounts Payable $4.66B$4.28B$4.23B$4.24B$4.11B$3.54B$2.90B$2.58B$2.61B$2.32B
Current Liabilities $16.35B$15.18B$12.65B$9.90B$9.58B$8.70B$7.76B$7.57B$6.16B$5.83B
Capital Leases $1.85B$1.86B$1.90B$1.75B$1.75B$1.67B$1.50B···
Total Liabilities ······$45.62B$42.12B$41.59B$39.39B
Long-term Debt $44.28B$43.03B$39.59B$38.08B$34.58B$31.00B$33.72B$32.82B$33.06B$31.38B
Total Debt $41.60B$43.03B$39.59B$38.08B$34.58B$31.00B$33.72B$32.82B$33.06B$31.38B
Retained Earnings $-5.72B$-2.12B$-1.35B$-2.28B$-532M$777M$-2.35B$-4.57B$-6.53B$-6.97B
AOCI $-305M$-387M$-425M$-490M$-404M$-502M$-460M$-381M$-278M$-338M
Stockholders' Equity $-6.03B$-2.50B$-1.77B$-2.77B$-933M$572M$-2.81B$-4.95B$-6.81B$-7.30B
Liabilities + Equity $60.72B$59.51B$56.21B$52.44B$50.74B$47.49B$45.06B$39.21B$36.59B$33.76B
Shares Outstanding 224,605,100249,981,400265,537,300277,378,300305,476,800339,425,600338,445,600342,895,200350,091,600370,535,900
Flujo de Efectivo 17
Métrica Tendencia 2025202420232022202120202019201820172016
D&A $3.52B$3.31B$3.08B$2.97B$2.85B$2.72B$2.60B$2.28B$2.13B$1.97B
Stock-based Comp $401M$360M$262M$341M$440M$362M$347M$268M$270M$251M
Amort. of Intangibles $12M$16M$20M$44M$25M$26M····
Other Non-cash $1.93B$1.08B$850M$-431M$-1.29B$2.40B$1.07B$461M$-3.53B$-2.67B
Operating Cash Flow $12.64B$10.51B$9.43B$8.52B$8.96B$9.23B$7.60B$6.76B$5.43B$5.65B
CapEx $4.94B$4.88B$4.74B$4.39B$3.58B$2.83B$4.16B$3.57B$3.02B$2.76B
Investing Cash Flow $-4.99B$-4.93B$-5.32B$-3.39B$-2.64B$-3.39B$-5.72B$-3.90B$-4.28B$-3.24B
Debt Issued $8.47B$7.50B$3.22B$6.00B$4.34B$2.70B$6.45B$2.00B$1.50B$5.40B
Net Debt Issued $1.08B$5.08B$2.31B$3.17B$475M$-737M$1.13B$296M$749M$925M
Stock Repurchased $10.07B$6.04B$3.81B$7.00B$8.21B$441M$1.03B$1.53B$2.05B$2.75B
Net Stock Activity $-10.07B$-6.04B$-3.81B$-7.00B$-8.21B$-441M$-1.03B$-1.53B$-2.05B$-2.75B
Dividends Paid $679M$690M$661M$653M$624M$153M$550M$487M$0·
Financing Cash Flow $-8.55B$-4.58B$-4.09B$-5.66B$-6.66B$-4.68B$-1.77B$-3.08B$-1.06B$-2.51B
Net Change in Cash $-893M$998M$27M$-543M$-342M$1.17B$119M$-230M$86M$-95M
Taxes Paid $1.74B$1.84B$1.39B$1.18B$2.18B$1.00B$849M$872M$1.21B$1.25B
Free Cash Flow $7.69B$5.64B$4.69B$4.13B$5.38B$6.40B$3.44B$3.19B$2.41B$2.89B
Levered FCF $5.91B$4.03B$3.16B$2.74B$4.15B$5.12B$2.00B$1.74B$1.35B$1.68B
Rentabilidad 5
Métrica Tendencia 2025202420232022202120202019201820172016
Net Margin 9.0%8.2%8.1%9.4%11.8%7.3%6.8%8.1%··
Pretax Margin 13.0%12.1%11.9%14.2%16.7%10.5%10.2%11.4%··
EBITDA Margin 4.7%4.7%4.7%4.9%4.9%5.3%5.1%4.9%··
ROA 11.3%10.0%9.7%10.9%14.2%8.1%8.3%10.0%6.3%8.7%
ROE -159.1%-269.6%-230.9%-305.0%-3853.7%-335.8%-90.4%-64.4%-31.4%-38.8%
Liquidez y Solvencia 4
Métrica Tendencia 2025202420232022202120202019201820172016
Current Ratio 1.01.11.21.41.41.41.41.31.61.6
Quick Ratio 0.70.80.91.01.01.01.11.01.21.1
Debt / Equity -6.9-17.2-22.3-13.8-37.154.2-12.0-6.6-4.9-4.3
LT Debt / Equity -6.9-15.3-21.0-13.6-36.853.8-12.0-6.5-4.8-4.3
Eficiencia 2
Métrica Tendencia 2025202420232022202120202019201820172016
Asset Turnover 1.31.21.21.21.21.11.21.2··
Receivables Turnover 7.06.86.97.17.87.17.27.0··
Por Acción 6
Métrica Tendencia 2025202420232022202120202019201820172016
Book Value / Share $-26.83$-10.00$-6.68$-9.98$-3.05$1.69$-8.30$-14.44$-19.44$-19.71
Revenue / Share $315.66$269.68$235.04$204.41$178.71$149.98$147.42$131.37··
Cash Flow / Share $52.76$40.16$34.12$28.92$27.25$26.87$21.83$19.03$14.58$14.28
Cash / Share $4.63$7.73$3.52$3.27$4.75$5.28$1.83$1.46$2.09$1.74
Dividend / Share $2.88$2.64$2.40$2.24$1.92$0.43$1.60$1.40··
EPS (TTM) $28.33$22.00$18.97$19.15$21.16$10.93$10.07$10.66$5.95$7.30
Tasas de Crecimiento 10
Métrica Tendencia 2025202420232022202120202019201820172016
Revenue YoY 7.1%8.7%7.9%2.5%14.0%·····
Revenue CAGR 3Y 7.9%6.3%8.0%·······
Revenue CAGR 5Y 8.0%·········
EPS YoY 28.8%16.0%-0.94%-9.5%93.6%·····
EPS CAGR 3Y 13.9%1.3%20.2%·······
EPS CAGR 5Y 21.0%·········
Net Income YoY 17.8%9.9%-7.1%-18.9%85.3%·····
Net Income CAGR 3Y 6.3%-6.1%11.8%·······
Net Income CAGR 5Y 12.6%·········
Dividends Paid CAGR 5Y 34.7%·········
Valoración (TTM) 17
Métrica Tendencia 2025202420232022202120202019201820172016
Revenue TTM $75.60B$70.60B$64.97B$60.23B$58.75B$51.53B$51.34B$46.68B$43.61B$41.49B
Net Income TTM $6.78B$5.76B$5.24B$5.64B$6.96B$3.75B$3.50B$3.79B$2.22B$2.89B
Market Cap $104.86B$75.03B$71.88B$66.56B$78.48B$55.82B$50.03B$42.67B$30.75B$27.43B
Enterprise Value $145.42B$116.13B$110.53B$103.74B$111.61B$84.92B$82.98B$74.95B$63.02B$58.11B
P/E 16.513.614.312.512.115.014.711.714.810.1
P/S 1.41.11.11.11.31.11.00.90.70.7
P/B -17.4-30.0-40.5-24.1-84.197.6-17.8-8.6-4.5-3.8
P / Tangible Book ·····97.6····
P / Cash Flow 8.37.17.67.88.86.06.66.35.74.9
P / FCF 13.613.315.316.114.68.714.513.412.89.5
EV / EBITDA 41.335.135.934.939.131.232.032.929.629.6
EV / FCF 18.920.623.625.120.713.324.123.526.120.1
EV / Revenue 1.91.61.71.71.91.61.61.61.41.4
Dividend Yield 0.65%0.92%0.92%0.98%0.80%0.27%1.1%1.1%0.00%·
Earnings Yield 6.1%7.3%7.0%8.0%8.2%6.7%6.8%8.6%6.8%9.9%
Payout Ratio 10.0%12.0%12.6%11.6%9.0%4.1%15.7%12.9%··
Annual Payout $679M$690M$661M$653M$624M$153M$550M$487M$0·

Período más reciente a la izquierda · valores nulos mostrados como ·

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

16
Métrica 2025-12-312024-12-312023-12-312022-12-312021-12-31
Ingresos $75.60B $70.60B $64.97B $60.23B $58.75B
Beneficio neto $6.78B $5.76B $5.24B $5.64B $6.96B
EPS Diluido $28.33 $22.00 $18.97 $19.15 $21.16

Propietarios institucionales (13F) 1 473 declarantes · $57.3B total · A fecha de 30 de septiembre de 2026

17

Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.

Tenedores 1 473
Valor en tenencia $57.3B
Nuevas posiciones 121
Posiciones cerradas 176
Actividad institucional — Q2 2026 vs trimestre anterior
Nuevas posiciones Posiciones cerradas Aumentado Disminuido Cambio neto de acciones
121 (-64 vs trimestre anterior) 176 (+72 vs trimestre anterior) 458 (-25 vs trimestre anterior) 581 (+4 vs trimestre anterior) -627K

Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.

Institución Valor Acciones % de 13F rastreadas Tipo
VANGUARD GROUP INC $6 870 392 526 14 716 173 12,00% Acciones
BlackRock, Inc. $5 069 973 824 13 003 600 8,85% Acciones
VANGUARD CAPITAL MANAGEMENT LLC $3 954 150 533 10 141 708 6,91% Acciones
Sanders Capital, LLC $3 442 060 818 8 828 287 6,01% Acciones
STATE STREET CORP $2 912 102 056 7 469 035 5,09% Acciones
WELLINGTON MANAGEMENT GROUP LLP $1 835 396 649 4 707 473 3,21% Acciones
GEODE CAPITAL MANAGEMENT, LLC $1 423 654 808 3 668 008 2,49% Acciones
First Eagle Investment Management, LLC $1 284 907 912 3 295 565 2,24% Acciones
VANGUARD PORTFOLIO MANAGEMENT LLC $1 057 704 509 2 712 828 1,85% Acciones
MORGAN STANLEY $1 008 556 857 2 586 771 1,76% Acciones
GOLDMAN SACHS GROUP INC $960 811 481 2 464 314 1,68% Acciones
JPMORGAN CHASE & CO $896 800 955 2 285 832 1,57% Acciones
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $861 456 107 2 209 485 1,50% Acciones
NORGES BANK $836 457 140 2 145 367 1,46% Acciones
Capital World Investors $770 864 224 1 977 121 1,35% Acciones
Capital International Investors $747 403 041 1 916 947 1,31% Acciones
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $709 859 997 1 500 000 1,24% Acciones
NORTHERN TRUST CORP $666 150 458 1 708 560 1,16% Acciones
FMR LLC $636 503 475 1 632 520 1,11% Acciones
Invesco Ltd. $596 390 232 1 529 637 1,04% Acciones
NORDEA INVESTMENT MANAGEMENT AB $553 702 529 1 429 943 0,97% Acciones
BARCLAYS PLC $514 349 127 1 319 216 0,90% Acciones
JANUS HENDERSON GROUP PLC $481 486 890 1 017 441 0,84% Acciones
Crake Asset Management LLP $449 072 183 1 151 792 0,78% Acciones
Metropolis Capital Ltd $430 915 307 910 564 0,75% Acciones
Darsana Capital Partners LP $428 879 000 1 100 000 0,75% Acciones
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $414 565 358 1 063 288 0,72% Acciones
Legal & General Group Plc $410 992 402 1 054 124 0,72% Acciones
FRANKLIN RESOURCES INC $399 958 688 1 025 824 0,70% Acciones
Life Cycle Investment Partners Ltd $355 737 196 912 404 0,62% Acciones
Bank of New York Mellon Corp $350 359 895 898 612 0,61% Acciones
VANGUARD FIDUCIARY TRUST CO $339 685 814 871 235 0,59% Acciones
ROYAL BANK OF CANADA $320 194 000 821 241 0,56% Acciones
LYRICAL ASSET MANAGEMENT LP $255 015 742 654 071 0,45% Acciones
BANK OF AMERICA CORP /DE/ $238 456 934 611 601 0,42% Acciones
SCHRODER INVESTMENT MANAGEMENT GROUP $237 236 367 608 470 0,41% Acciones
ROYAL LONDON ASSET MANAGEMENT LTD $235 649 908 604 401 0,41% Acciones
PRINCIPAL FINANCIAL GROUP INC $234 827 401 602 290 0,41% Acciones
UBS Group AG $230 953 291 592 355 0,40% Acciones
National Pension Service $230 650 346 591 578 0,40% Acciones
Russell Investments Group, Ltd. $206 832 565 530 340 0,36% Acciones
Nuveen, LLC $199 595 109 511 927 0,35% Acciones
Gobi Capital LLC $195 742 325 502 045 0,34% Acciones
Cryder Capital Partners LLP $194 561 738 499 017 0,34% Acciones
Allianz Asset Management GmbH $181 127 299 464 560 0,32% Acciones
DEUTSCHE BANK AG\ $175 985 429 451 372 0,31% Acciones
Swiss National Bank $172 097 446 441 400 0,30% Acciones
DIMENSIONAL FUND ADVISORS LP $172 079 393 441 313 0,30% Acciones
AustralianSuper Pty Ltd $159 635 782 409 438 0,28% Acciones
HSBC HOLDINGS PLC $158 555 065 406 750 0,28% Acciones

Mostrar todos los 1 473 propietarios institucionales →

Activistas y propietarios del %+ 5 4 tenencias

18

Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.

Declarante Presentado Participación Estado Propósito Presentación
Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan 10 de febrero de 2026 31,60% Presentación inicial · SEC
22 de noviembre de 2006 · Presentación inicial · SEC
Merrill Lynch Bank USA 11 de septiembre de 2006 · Presentación inicial · SEC
Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC 4 de agosto de 2006 · Presentación inicial · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Informantes de la empresa 92 insiders · 54 directivos · 31 consejeros

19
Insider Rol Última actividad Acciones en propiedad Compras 12m Ventas 12m Neto 12m
Samuel N Hazen CEO 10 de febrero de 2026 F 64 842 0 7 $-21 483 290
O'Boyle Michael P President & CEO - Parallon 26 de febrero de 2013 A 21 429 0 0 $0
Mike A Marks EVP and CFO 7 de mayo de 2026 G 46 576 0 0 $0
Bill B Rutherford CFO and EVP 16 de febrero de 2024 F 22 251 0 0 $0
Russell K Harms CFO - Central Group 17 de noviembre de 2006 D 0 0 0 $0
Robert Samuel Hankins JR CFO-Outpatient Services Group 17 de noviembre de 2006 D 0 0 0 $0
Richard J Shallcross CFO - Western Group 17 de noviembre de 2006 D 0 0 0 $0
Jeffrey T Crudele CFO-Eastern Division 1 de julio de 2005 F 13 865 0 0 $0
Erol R Akdamar Group President 12 de noviembre de 2024 M 6 843 0 0 $0
Timothy M Mcmanus Group President 31 de julio de 2024 M 27 008 0 0 $0
Richard A Hammett Group President 16 de febrero de 2024 F 17 936 0 0 $0
Charles J Hall Group President 11 de noviembre de 2022 M 202 443 0 0 $0
Bruce A Moore JR Group President - Service Line 11 de noviembre de 2022 S 30 807 0 0 $0
Paul W Rutledge Group President 31 de diciembre de 2012 A 335 657 0 0 $0
Beverly B Wallace President - Parallon 2 de noviembre de 2011 M 144 714 0 0 $0
Charles Robert Evans President - Eastern Group 26 de julio de 2006 A 62 173 0 0 $0
Marilyn B Tavenner President-Outpatient Svcs Grp 27 de octubre de 2005 A 26 154 0 0 $0
Greg Roth President-Ambulatory Surgery 31 de octubre de 2004 D 9 029 0 0 $0
Jay Grinney President-Eastern Group 7 de mayo de 2004 D 24 177 0 0 $0
Jon M Foster EVP and COO 10 de febrero de 2026 F 23 062 0 0 $0
Michael R Mcalevey EVP & Chief Legal & Admin Off. 26 de agosto de 2026 J 0 0 2 $-2 747 520
Jennifer Berres SVP & Chief Human Res. Officer 11 de febrero de 2026 S 11 993 0 2 $-4 126 932
Christopher F. Wyatt SVP & Controller 11 de febrero de 2026 S 44 379 0 1 $-2 020 000
Erica Rossitto SVP & Chief Nurse Executive 10 de febrero de 2026 F 10 407 0 0 $0
Michael S. Cuffe EVP and Chief Clinical Officer 10 de febrero de 2026 F 32 080 0 1 $-747 135
Sammie S Mosier SVP & Chief Nurse Executive 13 de febrero de 2025 F 11 113 0 0 $0
Kathleen M Whalen SVP & Chief Ethics Officer 14 de noviembre de 2024 S 9 454 0 0 $0
Phillip G Billington SVP-Internal Audit Services 12 de noviembre de 2024 M 52 702 0 0 $0
Joseph A Sowell III SVP; Chief Development Officer 5 de agosto de 2024 G 18 526 0 0 $0
Deborah M Reiner SVP - Mktg. & Communications 29 de julio de 2024 S 3 510 0 0 $0
Kathryn A. Torres SVP-Payer Contracting & Align. 25 de julio de 2024 S 17 755 0 0 $0
Jeffrey E. Cohen SVP-Government Relations 9 de mayo de 2024 S 5 185 0 0 $0
Chad J Wasserman SVP and CIO 18 de marzo de 2024 M 1 576 0 0 $0
Martin P. Paslick SVP and CIO 12 de abril de 2023 M 24 643 0 0 $0
Jane D. Englebright SVP and Chief Nursing Officer 9 de noviembre de 2021 S 0 0 0 $0
Robert A Waterman SVP & General Counsel 5 de mayo de 2021 S 50 062 0 0 $0
William J Morrow SVP - Finance and Treasurer 18 de febrero de 2021 F 5 578 0 0 $0
Sandra L. Morgan SVP-Provider Relations 18 de febrero de 2021 F 10 122 0 0 $0
Victor L Campbell SVP-Government Affairs 1 de mayo de 2019 A 194 145 0 0 $0
John M Steele SVP & Chief Human Res. Officer 25 de febrero de 2019 M 84 157 0 0 $0
Milton R Johnson Chairman 25 de febrero de 2019 M 881 823 0 0 $0
Ravi S. Chari SVP-Clinical Excellence 25 de febrero de 2018 M 7 003 0 0 $0
Alan R Yuspeh SVP & Chief Ethics Officer 25 de febrero de 2018 M 35 546 0 0 $0
Joseph N Steakley SVP-Internal Audit Services 25 de febrero de 2018 M 65 199 0 0 $0
Jana Joustra Davis SVP - Mktg. & Corp. Affairs 23 de mayo de 2017 M 26 378 0 0 $0
David Gwin Anderson SVP - Finance 7 de noviembre de 2016 M 110 167 0 0 $0
Donald W Stinnett SVP & Controller 25 de febrero de 2016 A 51 965 0 0 $0
Noel B Williams SVP and CIO 16 de mayo de 2012 M 299 030 0 0 $0
Jack O Bovender JR Chairman 6 de octubre de 2009 A 188 340 0 0 $0
Carl V George SVP - Development 27 de febrero de 2009 M 13 092 0 0 $0
Patricia T Lindler SVP - Government Programs 17 de noviembre de 2006 D 0 0 0 $0
Rosalyn S Elton SVP-Operations Finance 17 de noviembre de 2006 D 0 0 0 $0
Frank M Houser MD SVP-Quality & Medical Director 26 de julio de 2006 A 46 145 0 0 $0
James A Fitzgerald JR SVP-Supply Chain Operations 29 de enero de 2006 F 20 674 0 0 $0
Andrea B Smith Consejero 28 de abril de 2026 A 4 666 0 0 $0
William R Frist Consejero 28 de abril de 2026 A 13 740 0 0 $0
Wayne Joseph Riley Consejero 28 de abril de 2026 A 15 029 0 0 $0
Hugh F Johnston Consejero 28 de abril de 2026 A 4 475 0 0 $0
Thomas F Frist III Consejero 28 de abril de 2026 A 15 858 0 0 $0
Michael W Michelson Consejero 28 de abril de 2026 A 12 576 0 0 $0
Nancy Ann Deparle Consejero 28 de abril de 2026 A 21 910 0 0 $0
John Chidsey Consejero 28 de abril de 2026 A 1 305 0 0 $0
Robert J Dennis Consejero 29 de abril de 2025 A 26 601 0 0 $0
Meg Crofton Consejero 29 de abril de 2024 A 6 331 0 0 $0
Charles O Holliday JR Consejero 25 de abril de 2022 A 18 955 0 0 $0
Geoffrey G Meyers Consejero 1 de mayo de 2019 A 39 153 0 0 $0
John W Rowe Consejero 1 de mayo de 2019 A 30 388 0 0 $0
Ann H Lamont Consejero 2 de mayo de 2018 A 17 661 0 0 $0
Jay O Light Consejero 3 de mayo de 2017 A 30 953 0 0 $0
Stephen G Pagliuca Consejero 5 de diciembre de 2014 D 7 612 921 0 0 $0
Christopher R Gordon Consejero 1 de noviembre de 2013 D 30 003 156 0 0 $0
John Connaughton Consejero 1 de noviembre de 2013 D 30 003 156 0 0 $0
John H Mcarthur Consejero 17 de noviembre de 2006 D 0 0 0 $0
Kent C Nelson Consejero 17 de noviembre de 2006 D 0 0 0 $0
Magdalena Averhoff MD Consejero 17 de noviembre de 2006 D 0 0 0 $0
Glenda A Hatchett Consejero 17 de noviembre de 2006 D 0 0 0 $0
Frederick W Gluck Consejero 17 de noviembre de 2006 D 0 0 0 $0
Harold T Shapiro Consejero 17 de noviembre de 2006 D 0 0 0 $0
Michael C Armstrong Consejero 17 de noviembre de 2006 D 0 0 0 $0
Martin Feldstein Consejero 17 de noviembre de 2006 D 0 0 0 $0
Michael T Long Consejero 17 de noviembre de 2006 D 0 0 0 $0
ROYAL FRANK S Consejero 17 de noviembre de 2006 D 0 0 0 $0
Patricia F Elcan Propietario del 10% 6 de febrero de 2026 J 36 557 141 0 0 $0
Frisco Holding II Propietario del 10% 6 de febrero de 2026 J 36 557 141 0 0 $0
HERCULES HOLDING II, LLC Propietario del 10% 6 de febrero de 2026 J 32 282 889 0 0 $0
Thomas F Frist JR Propietario del 10% 6 de febrero de 2026 J 36 557 141 0 0 $0
Patricia C Frist Propietario del 10% 20 de febrero de 2018 G 0 0 0 $0
KKR PEI GP LTD Propietario del 10% 1 de abril de 2014 J 0 0 0 $0
Jonathan B Perlin · 2 de agosto de 2021 S 44 348 0 0 $0
Juan Vallarino · 9 de mayo de 2016 M 61 036 0 0 $0
Richard M Bracken · 31 de diciembre de 2014 F 82 499 0 0 $0
BANK OF AMERICA CORP /DE/ · 6 de noviembre de 2012 S 2 652 364 0 0 $0

Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto

Propiedad de ETFs Mantenido por 141 ETFs

20

El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.

Fondo Ponderación Unidades A fecha de Fuente
BUL · Pacer Funds Trust 5,07% 16 545 NS 31 de julio de 2026 N-PORT
IHF · iShares Trust 4,75% 147 977 SH 11 de septiembre de 2026 Diario
STNC · Hennessy Funds Trust 3,17% 7 315 NS 31 de julio de 2026 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 2,50% 97 403 SH 1 de octubre de 2026 Diario
COWZ · Pacer Funds Trust 2,07% 960 711 NS 31 de julio de 2026 N-PORT
WLTG · ETF Opportunities Trust 2,06% 3 942 NS 31 de julio de 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,65% 33 803 SH 1 de octubre de 2026 Diario
RPG · Invesco Exchange-Traded Fund Trust 1,30% 58 562 SH 1 de octubre de 2026 Diario
FLAG · Global X Funds 1,14% 48 NS 31 de julio de 2026 N-PORT
FCPI · FIDELITY COVINGTON TRUST 1,03% 6 909 NS 31 de julio de 2026 N-PORT
IYH · iShares Trust 1,01% 87 417 SH 11 de septiembre de 2026 Diario
SRHQ · Elevation Series Trust 0,94% 4 938 NS 31 de julio de 2026 N-PORT
NEAR · iShares U.S. ETF Trust 0,92% 48 109 000 SH 11 de septiembre de 2026 Diario
FHLC · FIDELITY COVINGTON TRUST 0,91% 74 445 NS 31 de julio de 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,90% 470 451 SH 19 de agosto de 2026 Diario
FXH · First Trust Exchange-Traded AlphaDE… 0,87% 22 725 NS 31 de julio de 2026 N-PORT
DIVB · iShares Trust 0,87% 42 100 SH 11 de septiembre de 2026 Diario
NFRA · FlexShares Trust 0,84% 62 628 NS 31 de julio de 2026 N-PORT
IXJ · iShares Trust 0,83% 81 708 SH 11 de septiembre de 2026 Diario
SPVM · Invesco Exchange-Traded Fund Trust 0,81% 2 483 SH 1 de octubre de 2026 Diario
QUVU · Hartford Funds Exchange-Traded Trust 0,79% 3 522 NS 31 de julio de 2026 N-PORT
BSCT · Invesco Exchange-Traded Self-Indexe… 0,78% 23 458 000 1 de octubre de 2026 Diario
BSCS · Invesco Exchange-Traded Self-Indexe… 0,74% 25 897 000 1 de octubre de 2026 Diario
CURE · Direxion Shares ETF Trust 0,72% 3 056 NS 31 de julio de 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,67% 12 075 SH 19 de agosto de 2026 Diario
LGDX · Tidal Trust III 0,66% 2 345 NS 31 de julio de 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0,55% 11 876 SH 19 de agosto de 2026 Diario
BSCR · Invesco Exchange-Traded Self-Indexe… 0,50% 22 893 000 1 de octubre de 2026 Diario
LSVD · ADVISORS' INNER CIRCLE FUND 0,46% 7 404 NS 31 de julio de 2026 N-PORT
WLDR · Two Roads Shared Trust 0,43% 964 NS 31 de julio de 2026 N-PORT
ROUS · Lattice Strategies Trust 0,42% 7 289 NS 31 de julio de 2026 N-PORT
RWL · Invesco Exchange-Traded Fund Trust … 0,41% 92 254 SH 1 de octubre de 2026 Diario
QLC · FlexShares Trust 0,39% 9 856 NS 31 de julio de 2026 N-PORT
XOEF · iShares Trust 0,37% 194 SH 11 de septiembre de 2026 Diario
GSY · Invesco Actively Managed Exchange-T… 0,36% 14 000 000 1 de octubre de 2026 Diario
UPSD · ETF Series Solutions 0,33% 972 NS 31 de julio de 2026 N-PORT
BSCU · Invesco Exchange-Traded Self-Indexe… 0,33% 9 324 000 1 de octubre de 2026 Diario
MGV · VANGUARD WORLD FUND 0,29% 97 604 SH 19 de agosto de 2026 Diario
PFIG · Invesco Exchange-Traded Fund Trust … 0,28% 390 000 1 de octubre de 2026 Diario
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0,28% 3 186 NS 31 de julio de 2026 N-PORT
USXF · iShares Trust 0,26% 9 226 SH 11 de septiembre de 2026 Diario
IUS · Invesco Exchange-Traded Self-Indexe… 0,26% 5 803 SH 1 de octubre de 2026 Diario
IWX · iShares Trust 0,23% 21 535 SH 11 de septiembre de 2026 Diario
VTV · VANGUARD INDEX FUNDS 0,23% 1 475 731 SH 19 de agosto de 2026 Diario
JMOM · J.P. Morgan Exchange-Traded Fund Tr… 0,23% 14 235 NS 31 de julio de 2026 N-PORT
MPLY · Strategy Shares 0,22% 87 NS 31 de julio de 2026 N-PORT
EUSA · iShares, Inc. 0,21% 9 589 SH 11 de septiembre de 2026 Diario
RSP · Invesco Exchange-Traded Fund Trust 0,21% 463 744 SH 1 de octubre de 2026 Diario
FTC · First Trust Exchange-Traded AlphaDE… 0,20% 6 420 NS 31 de julio de 2026 N-PORT
SIZE · iShares Trust 0,19% 1 920 SH 11 de septiembre de 2026 Diario
DYNF · BlackRock ETF Trust 0,19% 183 934 SH 11 de septiembre de 2026 Diario
VMAX · Lattice Strategies Trust 0,19% 228 NS 31 de julio de 2026 N-PORT
DSI · iShares Trust 0,19% 23 734 SH 11 de septiembre de 2026 Diario
ILCV · iShares Trust 0,18% 5 870 SH 10 de septiembre de 2026 Diario
IVW · iShares Trust 0,18% 331 185 SH 11 de septiembre de 2026 Diario
IUSG · iShares Trust 0,17% 136 713 SH 11 de septiembre de 2026 Diario
VOOG · VANGUARD ADMIRAL FUNDS 0,17% 115 334 SH 19 de agosto de 2026 Diario
IWD · iShares Trust 0,17% 332 035 SH 11 de septiembre de 2026 Diario
OMFL · Invesco Exchange-Traded Self-Indexe… 0,16% 17 845 SH 1 de octubre de 2026 Diario
VONV · VANGUARD SCOTTSDALE FUNDS 0,16% 90 157 SH 19 de agosto de 2026 Diario
USMV · iShares Trust 0,16% 89 855 SH 11 de septiembre de 2026 Diario
ACWV · iShares, Inc. 0,15% 11 903 SH 11 de septiembre de 2026 Diario
EGLE · Global X Funds 0,15% 8 NS 31 de julio de 2026 N-PORT
GLBL · Pacer Funds Trust 0,15% 4 NS 31 de julio de 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0,15% 33 327 SH 1 de octubre de 2026 Diario
VOXP · Advisors Series Trust 0,13% 18 NS 31 de julio de 2026 N-PORT
VRIG · Invesco Actively Managed Exchange-T… 0,12% 2 250 000 1 de octubre de 2026 Diario
TOPC · iShares Trust 0,12% 95 SH 11 de septiembre de 2026 Diario
DGRO · iShares Trust 0,12% 120 741 SH 11 de septiembre de 2026 Diario
QVML · Invesco Exchange-Traded Fund Trust … 0,11% 4 392 SH 1 de octubre de 2026 Diario
XVV · iShares Trust 0,11% 1 790 SH 11 de septiembre de 2026 Diario
IWL · iShares Trust 0,11% 5 786 SH 11 de septiembre de 2026 Diario
MGC · VANGUARD WORLD FUND 0,11% 31 176 SH 19 de agosto de 2026 Diario
ACIO · ETF Series Solutions 0,11% 6 205 NS 31 de julio de 2026 N-PORT
EVUS · iShares Trust 0,10% 934 SH 11 de septiembre de 2026 Diario
ADME · ETF Series Solutions 0,10% 751 NS 31 de julio de 2026 N-PORT
XRMI · Global X Funds 0,10% 126 NS 31 de julio de 2026 N-PORT
XCLR · Global X Funds 0,10% 9 NS 31 de julio de 2026 N-PORT
XYLD · Global X Funds 0,10% 8 148 NS 31 de julio de 2026 N-PORT
XTR · Global X Funds 0,10% 12 NS 31 de julio de 2026 N-PORT
PBUS · Invesco Exchange-Traded Fund Trust … 0,10% 26 763 SH 1 de octubre de 2026 Diario
BKLC · BNY Mellon ETF Trust 0,10% 13 621 NS 31 de julio de 2026 N-PORT
VV · VANGUARD INDEX FUNDS 0,10% 181 364 SH 19 de agosto de 2026 Diario
ESGV · VANGUARD WORLD FUND 0,10% 33 758 SH 19 de agosto de 2026 Diario
IVV · iShares Trust 0,10% 1 957 485 SH 11 de septiembre de 2026 Diario
PTLC · Pacer Funds Trust 0,10% 7 919 NS 31 de julio de 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0,10% 1 395 NS 31 de julio de 2026 N-PORT
PBP · Invesco Exchange-Traded Fund Trust 0,10% 877 SH 1 de octubre de 2026 Diario
EQAL · Invesco Exchange-Traded Fund Trust … 0,10% 1 791 SH 1 de octubre de 2026 Diario
ILCB · iShares Trust 0,10% 2 915 SH 11 de septiembre de 2026 Diario
BBUS · J.P. Morgan Exchange-Traded Fund Tr… 0,09% 20 766 NS 31 de julio de 2026 N-PORT
IYY · iShares Trust 0,09% 6 693 SH 11 de septiembre de 2026 Diario
VOTE · TCW ETF Trust 0,09% 2 545 NS 31 de julio de 2026 N-PORT
FEX · First Trust Exchange-Traded AlphaDE… 0,09% 3 614 NS 31 de julio de 2026 N-PORT
XYLG · Global X Funds 0,09% 147 NS 31 de julio de 2026 N-PORT
DFUS · Dimensional ETF Trust 0,09% 46 791 NS 31 de julio de 2026 N-PORT
IWB · iShares Trust 0,09% 103 721 SH 11 de septiembre de 2026 Diario
VOO · VANGUARD INDEX FUNDS 0,09% 4 034 357 SH 19 de agosto de 2026 Diario
TOV · EA Series Trust 0,09% 607 NS 31 de julio de 2026 N-PORT
SPUU · Direxion Shares ETF Trust 0,09% 586 NS 31 de julio de 2026 N-PORT
ITOT · iShares Trust 0,09% 202 387 SH 11 de septiembre de 2026 Diario
ACVF · ETF Opportunities Trust 0,09% 337 NS 31 de julio de 2026 N-PORT
GTOS · Invesco Actively Managed Exchange-T… 0,09% 104 000 1 de octubre de 2026 Diario
QDPL · Pacer Funds Trust 0,09% 3 708 NS 31 de julio de 2026 N-PORT
IWV · iShares Trust 0,09% 41 034 SH 11 de septiembre de 2026 Diario
DFAU · Dimensional ETF Trust 0,08% 25 516 NS 31 de julio de 2026 N-PORT
CRBN · iShares Trust 0,08% 2 269 SH 11 de septiembre de 2026 Diario
PHDG · Invesco Actively Managed Exchange-T… 0,08% 116 SH 1 de octubre de 2026 Diario
TOK · iShares Trust 0,08% 451 SH 11 de septiembre de 2026 Diario
VTI · VANGUARD INDEX FUNDS 0,08% 4 930 930 SH 19 de agosto de 2026 Diario
VONE · VANGUARD SCOTTSDALE FUNDS 0,08% 24 633 SH 19 de agosto de 2026 Diario
VTHR · VANGUARD SCOTTSDALE FUNDS 0,08% 12 577 SH 19 de agosto de 2026 Diario
HCMT · Direxion Shares ETF Trust 0,08% 1 081 NS 31 de julio de 2026 N-PORT
TILT · FlexShares Trust 0,08% 4 108 NS 31 de julio de 2026 N-PORT
SPXL · Direxion Shares ETF Trust 0,07% 12 141 NS 31 de julio de 2026 N-PORT
URTH · iShares, Inc. 0,07% 14 079 SH 11 de septiembre de 2026 Diario
ACWI · iShares Trust 0,06% 50 294 SH 11 de septiembre de 2026 Diario
HDUS · Lattice Strategies Trust 0,05% 275 NS 31 de julio de 2026 N-PORT
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,05% 125 729 SH 19 de agosto de 2026 Diario
DCOR · Dimensional ETF Trust 0,05% 3 816 NS 31 de julio de 2026 N-PORT
GLOF · iShares Trust 0,04% 202 SH 11 de septiembre de 2026 Diario
DUHP · Dimensional ETF Trust 0,04% 10 761 NS 31 de julio de 2026 N-PORT
DFAC · Dimensional ETF Trust 0,02% 28 662 NS 31 de julio de 2026 N-PORT
DFSU · Dimensional ETF Trust 0,02% 1 127 NS 31 de julio de 2026 N-PORT
DXUV · Dimensional ETF Trust 0,01% 99 NS 31 de julio de 2026 N-PORT
GTO · Invesco Actively Managed Exchange-T… 0,00% 42 000 30 de septiembre de 2026 Diario
CBLS · Elevation Series Trust -1,12% -1 546 NS 31 de julio de 2026 N-PORT
BIV · VANGUARD BOND INDEX FUNDS · · 15 de julio de 2026 Diario
BLV · VANGUARD BOND INDEX FUNDS · · 15 de julio de 2026 Diario
BSV · VANGUARD BOND INDEX FUNDS · · 15 de julio de 2026 Diario
BND · VANGUARD BOND INDEX FUNDS · · 15 de julio de 2026 Diario
VUSB · VANGUARD BOND INDEX FUNDS · · 15 de julio de 2026 Diario
VCRB · VANGUARD MALVERN FUNDS · · 15 de julio de 2026 Diario
VPLS · VANGUARD MALVERN FUNDS · · 15 de julio de 2026 Diario
VSDB · VANGUARD MALVERN FUNDS · · 15 de julio de 2026 Diario
VCSH · VANGUARD SCOTTSDALE FUNDS · · 15 de julio de 2026 Diario
VCIT · VANGUARD SCOTTSDALE FUNDS · · 15 de julio de 2026 Diario
VCLT · VANGUARD SCOTTSDALE FUNDS · · 15 de julio de 2026 Diario
VTC · VANGUARD SCOTTSDALE FUNDS · · 30 de julio de 2026 Diario
BNDW · VANGUARD SCOTTSDALE FUNDS · · 30 de julio de 2026 Diario
VCEB · VANGUARD WORLD FUND · · 30 de julio de 2026 Diario

HCA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

21
calificación · 30 analistas COMPRA
Objetivo mediano $450.00 +5,5%
6 20,0% Compra fuerte
11 36,7% Compra
12 40,0% Mantener
1 3,3% Venta
0 0,0% Venta fuerte

Precio objetivo a 12 meses

22 analistas · 2026-09-28

Objetivo medio $454.23 +6,5%

Ahora Precio Actual $426.69
Mín$380.00 Media$454.23 Máx$579.00

Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector

22

Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.

Ticker Capitalización Bursátil P/E Ingresos interanuales Margen Neto ROE Margen Bruto
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·
THC $17.28B 12.8 3.1% 11.1% 56.4% ·
EHC $10.61B 19.2 10.5% 9.5% 25.1% ·
UHS · 9.4 9.7% 8.6% 21.4% ·
ENSG $10.12B 29.8 18.7% 6.8% 16.9% ·
PACS $6.01B 31.5 29.3% 3.6% 23.1% ·
CON $2.53B 15.1 13.9% 7.7% 49.8% ·
BKD $2.57B -9.6 2.2% -8.2% -313.2% 26.2%
ACHC $1.28B -1.2 5.0% -33.3% -43.9% ·
SNDA $612M -7.7 25.2% -18.6% -197.2% ·

Últimas noticias Noticias recientes que mencionan a esta empresa

23

Señales de trading Señales recientes de compra/venta con precio de entrada y ratio riesgo/recompensa

25

Ninguna señal abierta en este momento — ninguna tarjeta está completada, y eso es honesto.

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

26

Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.

Tu selección se guarda y te sigue en todos los tickers.

Fuente: SEC 10-Q presentada el Jul 28, 2026